ConductScience.org, home

Paper · 32150819

Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus.

Rachdaoui N. Int J Mol Sci, 2020. Cited by 162 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus. Papers, record 32150819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32150819

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
9.7
iCite
Revised in PubMed
2020-12-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rachdaoui NNadia

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 2Major topic
Hypoglycemic AgentsMajor topic
InsulinMajor topic
Insulin ResistanceMajor topic
Animals
Homeostasis
Humans

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
5-2008-310JDRFUnited StatesPubMed
502-05Diabetes Association of Greater ClevelandPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References195

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,613,085Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?Diabetologia2013https://conductscience.org/library/papers/23613085PubMed
211,897,712Increased islet cell proliferation, decreased apoptosis, and greater vascularization leading to beta-cell hyperplasia in mutant mice lacking insulin.Endocrinology2002https://conductscience.org/library/papers/11897712PubMed
32,642,434Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion.Diabetes1989https://conductscience.org/library/papers/2642434PubMed
415,467,829Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.J Clin Invest2004https://conductscience.org/library/papers/15467829PubMed
515,467,831Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells.J Clin Invest2004https://conductscience.org/library/papers/15467831PubMed
624,384,568Insulin receptor signaling in normal and insulin-resistant states.Cold Spring Harb Perspect Biol2014https://conductscience.org/library/papers/24384568PubMed
75,543,636Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas.Diabetes1971https://conductscience.org/library/papers/5543636PubMed
89,202,395Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues.Mol Cell Endocrinol1997https://conductscience.org/library/papers/9202395PubMed
915,551,269Insulin and its receptor: structure, function and evolution.Bioessays2004https://conductscience.org/library/papers/15551269PubMed
107,040,963Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity.N Engl J Med1982https://conductscience.org/library/papers/7040963PubMed

Cited by110

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
42,958,671Jiangtang Xiaozhi formula alleviates type 2 diabetes mellitus by improving islet beta-cell dedifferentiation: a network pharmacology-based study.J Tradit Chin Med2026https://conductscience.org/library/papers/42958671PubMed
42,727,018Insulin Prescribing Challenges and Physician-Suggested Interventions: Evidence From a Tertiary Care Hospital in Lahore, Pakistan.Endocrinol Diabetes Metab2026https://conductscience.org/library/papers/42727018PubMed
42,534,817IGFBP-1 is associated with IRS signaling upregulation and contributes to metabolic recovery post-Roux-en-Y bypass.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42534817PubMed
42,520,203Trends in type 2 diabetes, prediabetes, and hyperglycemic recognition among menopausal women: A 20-year analysis of sociodemographic disparities.Womens Health (Lond)2026https://conductscience.org/library/papers/42520203PubMed
42,500,235Glycemic and lipid responses to selenium-enriched vs. zeaxanthin-enriched eggs in patients with type 2 diabetes: a 12-week randomized controlled trial.Front Nutr2026https://conductscience.org/library/papers/42500235PubMed
42,253,926Targeting Mitochondria in Aging-Related Diseases: Therapeutic Potential and Obstacles.MedComm (2020)2026https://conductscience.org/library/papers/42253926PubMed
42,131,482Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation.Front Physiol2026https://conductscience.org/library/papers/42131482PubMed
42,121,431A Novel Peptide Derived from Sea Buckthorn Leaves: Enzymatic Preparation, Dual Inhibitory Activity Against α-Glucosidase and DPP-IV, and Its Molecular Mechanism.Foods2026https://conductscience.org/library/papers/42121431PubMed
42,052,977Allostatic Load of Glucose Homeostasis, Epigenetic Biomarkers, and All-Cause and Cardiovascular Death: A Prospective Cohort Study.J Am Heart Assoc2026https://conductscience.org/library/papers/42052977PubMed
41,964,775Pheophytin a from Microcystis aeruginosa exerts antidiabetic activity in streptozotocin-induced diabetes in rat model.AMB Express2026https://conductscience.org/library/papers/41964775PubMed

1 to 10 of 110

See all 110 cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32150819

GET https://conductscience.org/api/papers/v1/32150819/references?page=2